You are here: HomeSolutionsIndustriesConsumer Health
print my pages

Country Report

Consumer Health in Georgia

May 2011

Price: $2,400

About this Report

About this Report

Delivery method: instant download
Report format: PDF doc_pdf.png (download a sample)
Market statistics: Excel workbook doc_excel_table.png (download a sample)

Overview

Discover the latest market trends and uncover sources of future market growth for the Consumer Health industry in Georgia with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Consumer Health industry in Georgia, our research will save you time and money while empowering you to make informed, profitable decisions.

When you purchase this report, you also get the data and the content from these category reports in Georgia for free:

The Consumer Health in Georgia market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth  
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Consumer Health in Georgia?
  • What are the major brands in Georgia?
  • What are the main trends in OTC Healthcare?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Sample Analysis

EXECUTIVE SUMMARY

Sales increase in 2010 thanks to economic recovery

The review period saw annual constant value sales decline for overall consumer health for each year other than 2010. Sales decline earlier in the review period was linked to growing price competition, as chained parapharmacies/drugstores continued to expand across the country. 2009 meanwhile saw a sharp sales decline as a result of the economic downturn, with consumers seeking to cut back their expenditure. However, economic recovery and a growing focus on domestic brands boosted sales in 2010, with sales growing in current value and constant value terms over the previous year.

Domestic players benefit from stronger distribution

The government is keen to make consumer health more affordable to Georgian consumers and thus encouraged the development of domestic production during the review period. In addition, domestic players GMP and Aversi-Rational benefited from their strong links with the PSP and Aversi chains in parapharmacies/drugstores respectively. These chains began to focus more on price competition in 2010, following the entry of lower-priced parapharmacies/drugstores operator Pharmadepot in 2009. Consequently, they began to expand the range of domestic products on offer and to improve their in-store placement as they sought a better-value positioning.

Multinationals continue to lead thanks to strong brands

However, multinationals continued to lead sales of consumer health in 2010, with the leading players being GlaxoSmithKline, A Menarini, Novartis, Altayvitaminy and SSP. These players generally benefit from offering a wide range of strong brands, such as Altayvitaminy’s Ingalipt pharyngeal preparations and A Menarini’s Nimesil combination products in cough, cold and allergy (hay fever) remedies. However, many multinationals lost share in 2010 due to stronger competition from domestic players and generic products, with Altayvitaminy and Krka both seeing a sharp decline in current value sales in the year.

Parapharmacies/drugstores further increases dominance

Parapharmacies/drugstores is the dominant distribution channel for consumer health, with this channel offering a wide range, expert pharmaceutical advice and frequent price promotions. The channel benefited from strong expansion during the review period, thus further gaining share in 2010 over the previous year. Internet retailing also saw strong current value sales growth in 2010 over the previous year, thanks to ongoing expansion in the household penetration of internet-enabled personal computers and growing consumer confidence in shopping online. In addition, direct selling gained a significant value share for the first time in 2010 thanks to the launch of Oriflame in the country.

Slow growth expected for forecast period

The constant value performance of consumer health is expected to be considerably stronger during the forecast period than that seen during the review period, when constant value sales declined. However, growth rates are expected to remain muted for a number of reasons. High prices and high levels of poverty will continue to constrain growth, with many consumers unable to buy consumer health frequently. In addition, Rx sales of consumer health remain strong, with these products being widely available UTC from parapharmacies/drugstores. As Georgia’s economy improves and disposable income levels rise, many are expected to trade up to Rx pharmaceuticals, believing these to offer a stronger or more rapid effect.

Table of Contents

Table of Contents

Consumer Health in Georgia - Industry Overview

EXECUTIVE SUMMARY

Sales increase in 2010 thanks to economic recovery

Domestic players benefit from stronger distribution

Multinationals continue to lead thanks to strong brands

Parapharmacies/drugstores further increases dominance

Slow growth expected for forecast period

MARKET INDICATORS

  • Table 1 Consumer Expenditure on Health Goods and Medical Services 2005-2010
  • Table 2 Life Expectancy at Birth 2005-2010

MARKET DATA

  • Table 3 Sales of Consumer Health by Category: Value 2005-2010
  • Table 4 Sales of Consumer Health by Category: % Value Growth 2005-2010
  • Table 5 Consumer Health Company Shares 2006-2010
  • Table 6 Consumer Health Brand Shares 2007-2010
  • Table 7 Sales of Consumer Health by Distribution Format: % Analysis 2005-2010
  • Table 8 Sales of Consumer Health by Category and Distribution Format: % Analysis 2010
  • Table 9 Forecast Sales of Consumer Health by Category: Value 2010-2015
  • Table 10 Forecast Sales of Consumer Health by Category: % Value Growth 2010-2015

APPENDIX

OTC registration and classification

Generics

Combination products

Advertising

Packaging

Distribution

Vitamins and dietary supplements registration and classification

Self-medication/self-care and preventative medicine

Switches

DEFINITIONS

  • Summary 1 Research Sources

Consumer Health in Georgia - Company Profiles

Aversi-Rational Ltd in Consumer Health (Georgia)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 4 Aversi-Rational Ltd: Competitive Position 2010

Gama Ltd in Consumer Health (Georgia)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 7 Gama Ltd: Competitive Position 2010

GM Pharmaceuticals Ltd (GMP) in Consumer Health (Georgia)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 10 GM Pharmaceuticals Ltd (GMP): Competitive Position 2010

Adult Mouth Care in Georgia - Category Analysis

HEADLINES

TRENDS

  • Adult mouth care saw a return to growth in 2010 as the Georgian economy began to recover. Adult mouth care has a wide consumer appeal in Georgia but during the economic uncertainty seen in 2009 many consumers cut back on their purchases. Consequently, current value sales declined by 4% in the year. However, a return to economic growth in 2010 enabled consumers to better afford adult mouth care, with current value sales consequently growing by 7% in the year.

SWITCHES

COMPETITIVE LANDSCAPE

  • GlaxoSmithKline was the leading player in adult mouth care in 2010 with 19% value share derived from its Calgel, Corsodyl and Sensodyne brands. These brands benefit from offering a strong global reputation and wide distribution. However, Sensodyne lost almost half a percentage point in value share in 2010 over the previous year as the strong marketing support seen earlier in the review period died away and consumers became increasingly focused on price.

PROSPECTS

  • There is expected to be a growing focus on oral health during the forecast period. This will be linked to the growth of the grooming trend in Georgia but will also be due to deteriorating national oral health as a result of unhealthier diets. Dental treatments are very expensive in Georgia, with consumers thus likely to become more proactive in taking care of their teeth. This trend is likely to hinder sales of adult mouth care, as the incidence of gum disorders and untreated cavities reduces.

CATEGORY DATA

  • Table 11 Sales of Adult Mouth Care: Value 2005-2010
  • Table 12 Sales of Adult Mouth Care: % Value Growth 2005-2010
  • Table 13 Adult Mouth Care Company Shares 2006-2010
  • Table 14 Adult Mouth Care Brand Shares 2007-2010
  • Table 15 Forecast Sales of Adult Mouth Care: Value 2010-2015
  • Table 16 Forecast Sales of Adult Mouth Care: % Value Growth 2010-2015

Analgesics in Georgia - Category Analysis

HEADLINES

TRENDS

  • 2010 saw the publication of reports linking metamizolum to potentially lethal side effects. Metamizolum is the main active ingredient in dipyrone and was singled out by the World Health Organisation and a number of research studies carried out in Georgia as encouraging the development of agranulocytosis, a life-threatening condition characterised by a lowered neutrocyte level in the blood. According to recent data, the risk of developing this complication as a side effect ranges from 0.2-2 cases in a million doses but if the condition is developed, 7% of cases are likely to result in death. As a result, Aventis’ popular brand Baralgin was removed in 2010. Dipyrone sales however continued to remain strong, with this being the fourth most significant product area in overall adult analgesics at the end of the review period and accounting for 11% unit volume share. This was due to a lack of consumer awareness of associated health risks and limited media coverage.

SWITCHES

COMPETITIVE LANDSCAPE

  • The leading player in analgesics is A Menarini, which held 14% value share in 2010 with its Nimesil and Fastum brands. Nimesil is the leading brand in systemic analgesics, where it accounted for 10% value share in 2010, while Fastum Gel led topical analgesics/anaesthetic with a strong 35% value share. The company benefits from wide distribution via parapharmacies/drugstores and also from strong advertising support. Due to the company’s presence in the leading parapharmacies/drugstores chains, it benefited from the ongoing expansion of chains such as Aversi and PSP across the country.

PROSPECTS

  • There is expected to be an ongoing expansion in parapharmacies/drugstores during the forecast period, with leading players PSP and Aversi set to further expand their networks. These players are also expected to further expand their presence in healthcare, opening new clinics and hospitals. This expansion is expected to greatly benefit their associated manufacturing companies GMP and Aversi-Rational. These players are expected to launch a wider range of analgesics during the forecast period and with strong distribution are expected to see a rapid growth of share.

CATEGORY DATA

  • Table 17 Sales of Analgesics by Category: Value 2005-2010
  • Table 18 Sales of Analgesics by Category: % Value Growth 2005-2010
  • Table 19 Analgesics Company Shares 2006-2010
  • Table 20 Analgesics Brand Shares 2007-2010
  • Table 21 Forecast Sales of Analgesics by Category: Value 2010-2015
  • Table 22 Forecast Sales of Analgesics by Category: % Value Growth 2010-2015

Calming and Sleeping in Georgia - Category Analysis

HEADLINES

TRENDS

  • 2010 was marked by a significant change in strategy for Aversi and PSP, the leading chains in parapharmacies/drugstores. Due to the entry of Pharmadepot in 2009 there was a marked increase in price competition, with this retailer offering prices 10-20% lower than those of Aversi and PSP. Consequently, the leading parapharmacies/drugstores increased their use of price promotions but also began to focus on domestic brands, increasingly prioritising these products in their displays.

SWITCHES

COMPETITIVE LANDSCAPE

  • Krewel Meuselbach was the leading player in calming and sleeping in 2010, with its Valocordin brand accounting for 17% value share. This brand benefits from a longstanding presence in Georgia and thus enjoys strong customer loyalty. It also benefits from frequent recommendations from pharmacists and doctors. However, the brand lost share slightly in 2010 over the previous year, with this chiefly due to stronger competition from domestic players.

PROSPECTS

  • Calming and sleeping is expected to benefit strongly from ongoing urbanisation and expected economic growth in Georgia during the forecast period. Consumers are likely to lead increasingly stressful lifestyles, with many working longer hours and living in more cramped conditions. This is expected to result in growing interest in calming and sleeping overall, while these products are expected to become increasingly widely available via chained parapharmacies/drugstores.

CATEGORY DATA

  • Table 23 Sales of Calming and Sleeping: Value 2005-2010
  • Table 24 Sales of Calming and Sleeping: % Value Growth 2005-2010
  • Table 25 Calming and Sleeping Company Shares 2006-2010
  • Table 26 Calming and Sleeping Brand Shares 2007-2010
  • Table 27 Forecast Sales of Calming and Sleeping: Value 2010-2015
  • Table 28 Forecast Sales of Calming and Sleeping: % Value Growth 2010-2015

Cough, Cold and Allergy (Hay Fever) Remedies in Georgia - Category Analysis

HEADLINES

TRENDS

  • 2010 saw a record-breaking hot summer in Georgia, which resulted in the increased incidence of coughs and colds and also in growing consumer caution. Many believe that excessively hot weather enables flu viruses to spread more easily and thus took greater precautions during the warm weather. This resulted in consumers being more likely to buy cough, cold and allergy (hay fever) remedies at the first signs of illness, with this trend supporting strong sales.

SWITCHES

COMPETITIVE LANDSCAPE

  • The leading player in cough, cold and allergy (hay fever) remedies is GlaxoSmithKline Plc which held 9% value share in 2010. The company offers a wide range of products, including Augmentin, Coldrex, Panadol and Imigran in combination products, Ventolin and Salbutamol in nasal sprays and Actifed in antihistamines/allergy remedies (systemic. The company owes its leading position to its wide range of products and strong marketing support.

PROSPECTS

  • Economic recovery during the forecast period is expected to result in a further rise in disposable income levels, with this also likely to result in the more frequent consumption of some cough, cold and allergy (hay fever) remedies. Medicated confectionery and pharyngeal preparations are expected to benefit most from this trend, seeing current value growth of 5% and 3% as a result. These products are expected to see increasingly casual consumption, with many consumers taking these products to ward off the first symptoms of coughs or sore throats.

CATEGORY DATA

  • Table 29 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2005-2010
  • Table 30 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2005-2010
  • Table 31 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares 2006-2010
  • Table 32 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares 2007-2010
  • Table 33 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2010-2015
  • Table 34 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2010-2015

Digestive Remedies in Georgia - Category Analysis

HEADLINES

TRENDS

  • There was strong growth in sales for consumer foodservice in Georgia during the review period, with fast food and pizza consumer foodservice performing particularly well. This was chiefly due to the expansion of chains, with global brands such as McDonald’s proving hugely successful among younger Georgians. There was also strong growth for convenient and indulgent packaged food, including ready meals and sweet and savoury snacks, and for carbonates, with this driven by strong advertising and busier lifestyles. While these food products and beverages offer indulgence and a modern image, however, many find them to be more indigestible. Consequently, the growing popularity of fast food, convenience food and carbonates boosted sales of digestive remedies, as consumers sought to relieve uncomfortable symptoms.

SWITCHES

COMPETITIVE LANDSCAPE

  • Sanofi-Synthélabo leads sales in digestive remedies, accounting for 11% of value in 2010. This player owes its strong position to the popularity of No-spa in IBS treatments. This brand has been present in Georgia for many years and consequently benefits from strong consumer awareness and loyalty. Sanofi-Synthélabo is closely followed by A Menarini with 9% share derived from its Mezym digestive enzymes and Espumisan antiflatulents and H2 blockers.

PROSPECTS

  • Growth in digestive remedies will continue to be driven by consumers’ changing lifestyles. Chained fast food players will continue to expand across the country, while consumers will be increasingly attracted by the convenience and indulgence offered by processed food and carbonates. Georgia is expected to see good economic growth during the forecast period but this is likely to be accompanied by busier lifestyles and higher levels of stress. Consequently, consumers are expected to increasingly suffer from acidity, indigestion, constipation and diarrhoea as their digestive systems struggle to cope with these changes.

CATEGORY DATA

  • Table 35 Sales of Digestive Remedies by Category: Value 2005-2010
  • Table 36 Sales of Digestive Remedies by Category: % Value Growth 2005-2010
  • Table 37 Digestive Remedies Company Shares 2006-2010
  • Table 38 Digestive Remedies Brand Shares 2007-2010
  • Table 39 Forecast Sales of Digestive Remedies by Category: Value 2010-2015
  • Table 40 Forecast Sales of Digestive Remedies by Category: % Value Growth 2010-2015

Ear Care in Georgia - Category Analysis

HEADLINES

TRENDS

  • Consumers are typically reluctant to self-medicate when it comes to ear-related problems, preferring to seek medical advice. This consequently results in Rx medicines dominating sales, with most likely to simply make repeat purchases of remedies that they were previously prescribed. Rx ear care is widely available in Georgia, with few controls on the sale of these products via parapharmacies/drugstores. Consequently, OTC ear care sales remained small in 2010 at less than GEL1 million.

SWITCHES

COMPETITIVE LANDSCAPE

  • Sanofi-Aventis remained the leading player in ear care in 2010, with its Sofradex brand accounting for 23% value share. This brand has a long history in Georgia and consequently benefits from wide distribution and strong awareness among ear care users. However, Sanofi-Aventis saw the sharpest decline in value share in 2010 over the previous year, dropping by two percentage points. This was chiefly due to stronger competition from other players, as parapharmacies/drugstores expanded the range of ear care on offer.

PROSPECTS

  • A lack of investment in ear care will continue to limit sales during the forecast period, with value sales likely to remain below GEL1 million in constant value terms in 2015. Players are reluctant to invest in new product development or advertising for ear care due to poor sales. However, poor sales are chiefly due to low consumer awareness, with this unlikely to be improved unless the leading players invest in consumer education campaigns.

CATEGORY DATA

  • Table 41 Sales of Ear Care: Value 2005-2010
  • Table 42 Sales of Ear Care: % Value Growth 2005-2010
  • Table 43 Ear Care Company Shares 2006-2010
  • Table 44 Ear Care Brand Shares 2007-2010
  • Table 45 Forecast Sales of Ear Care: Value 2010-2015
  • Table 46 Forecast Sales of Ear Care: % Value Growth 2010-2015

Emergency Contraception in Georgia - Category Analysis

HEADLINES

TRENDS

  • The government is keen to encourage a better awareness of birth control methods in Georgia and invested in reproductive health consultants and centres during the review period. As a result of this development, there was a marked rise in the number of legal abortions during the review period. There was also a strong drop in the percentage of births outside of marriage, with this dropping form 50% of overall births in 2005 to just 32% share in 2010. The stronger provision of reproductive healthcare also widened consumers’ awareness of the differing contraceptive methods available and also improved availability. This strongly benefited emergency contraception.

COMPETITIVE LANDSCAPE

  • Richter Gedeon dominated sales of emergency contraception throughout the review period, rising from 92% value share in 2005 to 98% share in 2010. At the start of the review period, “others” accounted for 8% value share. However, these players struggled to compete with Richter Gedeon and many exited during the review period, with a marked drop in share for “others” as a result. Richter Gedeon has strong distribution links with the leading chains in parapharmacies/drugstores and its Postinor brand enjoys a strong reputation.

PROSPECTS

  • The forecast period is expected to see weaker growth in comparison to that seen during the review period, with a constant value CAGR of 5% and 26% respectively. The review period saw dynamic growth from a low sales base. Growth in the forecast period will be from a considerably higher sales base and will thus be weaker. The monopoly position enjoyed by Richter Gedeon will hinder sales, with this player having little incentive to invest in new product development or marketing. Many women will remain reticent in purchasing emergency contraception, due to a lack of consumer education campaigns.

CATEGORY DATA

  • Table 47 Sales of Emergency Contraception: Value 2005-2010
  • Table 48 Sales of Emergency Contraception: % Value Growth 2005-2010
  • Table 49 Emergency Contraception Company Shares 2006-2010
  • Table 50 Emergency Contraception Brand Shares 2007-2010
  • Table 51 Forecast Sales of Emergency Contraception: Value 2010-2015
  • Table 52 Forecast Sales of Emergency Contraception: % Value Growth 2010-2015

Eye Care in Georgia - Category Analysis

HEADLINES

TRENDS

  • Two main trends boosted sales of eye care during the review period. Firstly, there was growing popularity for contact lenses, as these became more widely available in Georgia and also more affordable. Rising disposable income levels encouraged consumers to invest more in their appearance, which resulted in many switching from glasses to contact lenses. While products specifically designed for contact lens users are excluded from eye care according to Euromonitor International definitions, many contact lens wearers save money by buying standard eye care instead.

SWITCHES

COMPETITIVE LANDSCAPE

  • Slavyanskaya Apteka was the leading player in eye care in 2010 with a strong 24% value share. This Russian player offers the Levomicetin and Albucid brands in standard eye care and benefits from offering affordable prices. The company increased its exports into Georgia in the last two years of the review period, which resulted in a strong growth in value share. Consequently, the company gained an additional two percentage points in value share in 2010.

PROSPECTS

  • The forecast period is expected to see ongoing strong growth in the use of contact lenses and computers in Georgia, with this underpinned by rising disposable income levels as the country’s economy grows. Computer usage is expected to increase dramatically, both in terms of frequency and the number of those using computers on a regular basis. This will be partly due to growth in services and urbanisation, with a growing number of Georgians working in modern offices and using computers. Growth will also be due to a sharp rise in the household penetration of personal computers and the internet. However, the widening use of contact lenses and computers is expected to result in consumers suffering from tired or dry eyes more frequently, which will support sales growth in eye care.

CATEGORY DATA

  • Table 53 Sales of Eye Care by Category: Value 2005-2010
  • Table 54 Sales of Eye Care by Category: % Value Growth 2005-2010
  • Table 55 Standard Eye Care by Type: % Value Breakdown 2007-2010
  • Table 56 Eye Care Company Shares 2006-2010
  • Table 57 Eye Care Brand Shares 2007-2010
  • Table 58 Forecast Sales of Eye Care by Category: Value 2010-2015
  • Table 59 Forecast Sales of Eye Care by Category: % Value Growth 2010-2015

Herbal/Traditional Products in Georgia - Category Analysis

HEADLINES

TRENDS

  • Leading parapharmacies/drugstores chains Aversi and PSP adjusted their product strategies in 2010, with these companies opting to focus more on affordable domestic products as they sought to improve consumers’ access to healthcare. These chains consequently began to offer a wider range of domestic brands and improved their in-store positioning. Within herbal/traditional products this benefited GMP most, due to this company’s strong ties with the PSP chain. GMP capitalised on this by investing heavily in promotion for its Somna Ritz calming and sleeping. However, other local brands also saw stronger distribution as a result, with many local players consequently investing more in their brands. Turmanidze, Kardu’s Kolkhuri and Salkhino were relaunched in 2010 and strongly promoted.

COMPETITIVE LANDSCAPE

  • There was a marked change in the competitive landscape of herbal/traditional products in 2010. In 2009, there were a number of players jostling for the leading position, with GMP, Iberia, Unique Pharmaceutical, Krewel Meuselbach, NeoPharmi and Kardu each having 5% value share. These players remained strong in 2010, benefiting from offering strong brands such as Kardu’s Kolkhuri, which dominates herbal/traditional analgesics, and Iberia’s Evkalipt, the leading brand in herbal/traditional cough, cold and allergy (hay fever) remedies. They also benefit from wide distribution.

PROSPECTS

  • The strong tradition of herbal medicine in Georgia is expected to receive growing attention during the forecast period. The Georgian government is keen to offer Georgians more affordable healthcare options, while the leading chains in parapharmacies/drugstores are also increasingly focused on price. Consequently, the government is expected to encourage the development of a wider range of domestic herbal/traditional products, due to their affordable nature, with these likely to obtain strong distribution via parapharmacies/drugstores.

CATEGORY DATA

  • Table 60 Sales of Herbal/Traditional Products: Value 2005-2010
  • Table 61 Sales of Herbal/Traditional Products: % Value Growth 2005-2010
  • Table 62 Herbal/Traditional Products Company Shares 2006-2010
  • Table 63 Herbal/Traditional Products Brand Shares 2007-2010
  • Table 64 Forecast Sales of Herbal/Traditional Products: Value 2010-2015
  • Table 65 Forecast Sales of Herbal/Traditional Products: % Value Growth 2010-2015

Medicated Skin Care in Georgia - Category Analysis

HEADLINES

TRENDS

  • Medicated skin care was boosted by a very hot summer in 2010, which resulted in many of those suffering from skin disorders experiencing stronger symptoms. Those suffering from fungal complaints for example found them more uncomfortable, while allergies, pruritus, acne and haemorrhoids also tended to flare up. Consequently, many consumers began to use medicated skin care with greater frequency in order to alleviate their symptoms.

SWITCHES

COMPETITIVE LANDSCAPE

  • The leading player in medicated skin care is Nizhpharm, which held 9% value share in 2010. This company offers a wide range of medicated skin care, including Nystatin in vaginal antifungals, Erythromycin and Sintomicin in topical germicidals/antiseptics, Hydrocortisone in antipruritics and Oblepikhovye suppositorii and Anestesol in haemorrhoid treatments. The company benefits from this wide range and also from its well-trusted brands, which are supported by strong in-store promotion.

PROSPECTS

  • There is expected to be growing awareness about skin problems during the forecast period and also growing awareness of the solutions and remedies on offer. Consumer awareness will be driven by stronger advertising for many products, both from OTC medicated skin care and from cosmetic skin care players. In addition, the leading chains in parapharmacies/drugstores, such as Aversi, PSP and Pharmadepot, will conduct consumer education campaigns and offer free consultations, often alongside free samples. Consequently, consumers are expected to become more confident in their self-medication during the forecast period and are expected to buy a wider range of medicated skin care.

CATEGORY DATA

  • Table 66 Sales of Medicated Skin Care by Category: Value 2005-2010
  • Table 67 Sales of Medicated Skin Care by Category: % Value Growth 2005-2010
  • Table 68 Medicated Skin Care Company Shares by Value 2006-2010
  • Table 69 Medicated Skin Care Brand Shares 2007-2010
  • Table 70 Hair Loss Treatments Brand Shares 2007-2010
  • Table 71 Forecast Sales of Medicated Skin Care by Category: Value 2010-2015
  • Table 72 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2010-2015

Vitamins and Dietary Supplements in Georgia - Category Analysis

HEADLINES

TRENDS

  • 2009 saw a marked downturn in the everyday consumption of vitamins and dietary supplements, with supplements taken by many consumers as a preventative daily measure seeing strong sales decline. Multivitamins saw 3% current value sales decline in the year, while omega-3-6-9 (fish and non-fish) declined by 5%, probiotic supplements by 3% and calcium supplements by 4%. However, as the Georgian economy returned to growth in 2010, these everyday supplements also saw renewed growth, with current value sales rising by 6-7% each in the year.

VITAMINS

DIETARY SUPPLEMENTS

PROSPECTS

  • There is expected to be strong growth for the health and wellness trend in Georgia during the forecast period, with consumers becoming more proactive when it comes to their health. However, this will not necessarily benefit vitamins and dietary supplements. Many consumers continue to regard fresh fruit, vegetables and herbs as the best source of nutrients, with the country’s production of high quality products in this area thus posing strong competition for vitamins and dietary supplements. Many also see a specific herbalist to have dietary supplements made up for them, while home-made tonics are also popular.

CATEGORY DATA

  • Summary 11 Dietary Supplements: Brand Ranking by Positioning 2010
  • Table 73 Sales of Vitamins and Dietary Supplements by Category: Value 2005-2010
  • Table 74 Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2005-2010
  • Table 75 Dietary Supplements by Positioning 2006-2010
  • Table 76 Vitamins and Dietary Supplements Company Shares 2006-2010
  • Table 77 Vitamins and Dietary Supplements Brand Shares 2007-2010
  • Table 78 Vitamins Brand Shares 2007-2010
  • Table 79 Dietary Supplements Brand Shares 2007-2010
  • Table 80 Forecast Sales of Vitamins and Dietary Supplements by Category: Value 2010-2015
  • Table 81 Forecast Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2010-2015

Weight Management in Georgia - Category Analysis

HEADLINES

TRENDS

  • Georgian consumers are increasingly focused on losing weight. However, 2009 saw 1% dip in sales as the economic downturn resulted in consumers seeking more affordable methods, with a growing focus on calorie restriction in the year. As the economy returned to growth, consumers however became more willing to pay for easier and more pleasurable alternatives, with slimming teas and weight loss supplements consequently returning to current value growth in the year.

COMPETITIVE LANDSCAPE

  • The leading player in weight management products is Bional, which held a strong 49% value share in 2010 with its Apple Slim Extra weight loss supplements. Apple Slim Extra benefits from wide distribution and also offers a more affordable pack price in comparison to other weight loss supplements. Apple Slim Extra was priced at GEL23.50 for 40 units in 2010, thus offering a higher unit price than Ajanta’s Figurin at GEL25.00 for 60 units but a lower initial outlay. Bional also spends the most on advertising within weight management, using TV, radio and magazine advertising.

PROSPECTS

  • Changing lifestyles in Georgia suggest that weight problems will become more pronounced during the forecast period. The country is expected to see good economic growth and ongoing urbanisation, with this resulting in consumers leading increasingly sedentary lifestyles. In addition, fast food chains and supermarkets/hypermarkets are expected to continue to spread across the country, with consumers becoming increasingly reliant on processed food and consumer foodservice. Despite this, most consumers will continue to equate slimness with beauty, particularly among women, with this fuelling a growing interest in weight control methods.

CATEGORY DATA

  • Table 82 Sales of Weight Management by Category: Value 2005-2010
  • Table 83 Sales of Weight Management by Category: % Value Growth 2005-2010
  • Table 84 Weight Management Company Shares 2006-2010
  • Table 85 Weight Management Brand Shares 2007-2010
  • Table 86 Forecast Sales of Weight Management by Category: Value 2010-2015
  • Table 87 Forecast Sales of Weight Management by Category: % Value Growth 2010-2015

Wound Care in Georgia - Category Analysis

HEADLINES

TRENDS

  • Sales growth for wound care dipped in 2009, as consumers sought to save money. Consequently, in this year they tend to purchase these products only as and when needed. In 2010, however, rising economic confidence resulted in many consumers stocking up on wound care, which are regarded as useful products to keep in stock in case of accidents.

COMPETITIVE LANDSCAPE

  • Betasan was the leading player in wound care in 2010, holding 27% value share with its Santavik and Betasan brands. This Turkish player benefits from offering affordable prices and also from offering a wide range of pack sizes, ranging from 10 to 100 units. The company also benefits from offering innovative products containing natural extracts, such as capsicum and zinc oxide to assist in healing and relieve pain. Betasan also has the widest distribution within wound care.

PROSPECTS

  • Georgia’s economic recovery is expected to continue to benefit wound care during the forecast period. As consumers’ disposable income levels increase, consumers are likely to trade up to increasingly specialised and value-added products. Wound care for specific body parts, such as hands or feet, is likely to gain share, as will products targeted at specific consumer groups such as sports enthusiasts. Products with additional functional ingredients, such as the capsicum and zinc oxide sticking plasters/adhesive bandages are expected to gain share. The leading players in wound care are expected to respond to this trend by launching new delivery formats, meanwhile, with spray-on sticking plasters/adhesive bandages thus likely to become significant during the forecast period.

CATEGORY DATA

  • Table 88 Sales of Wound Care by Category: Value 2005-2010
  • Table 89 Sales of Wound Care by Category: % Value Growth 2005-2010
  • Table 90 Wound Care Company Shares 2006-2010
  • Table 91 Wound Care Brand Shares 2007-2010
  • Table 92 Forecast Sales of Wound Care by Category: Value 2010-2015
  • Table 93 Forecast Sales of Wound Care by Category: % Value Growth 2010-2015

Segmentation

Segmentation

This market research report includes the following:

  • Consumer Health
    • OTC
      • Adult Mouth Care
      • Analgesics
        • Systemic Analgesics
          • Adult Analgesics
            • Acetaminophen
            • Aspirin
            • Combination Products - Analgesics
            • Diclofenac
            • Dipyrone
            • Ibuprofen
            • Ketoprofen
            • Naproxen
          • Child-Specific Analgesics
            • Child-Specific Acetaminophen
            • Child-Specific Aspirin
            • Child-Specific Combination Products - Analgesics
            • Child-Specific Diclofenac
            • Child-Specific Dipyrone
            • Child-Specific Ibuprofen
            • Child-Specific Ketoprofen
            • Child-Specific Naproxen
        • Topical Analgesics/Anaesthetic
      • Calming and Sleeping
      • Cough, Cold and Allergy (Hay Fever) Remedies
        • Antihistamines/Allergy Remedies (Systemic)
        • Child-Specific Cough, Cold and Allergy Remedies
          • Child-Specific Allergy Remedies
          • Child-Specific Cough/Cold Remedies
        • Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies
        • Cough Remedies
        • Decongestants
          • Nasal Sprays
          • Oral Decongestants
          • Inhalant Decongestants
          • Decongestant Rubs
          • Nasal Decongestant Drops
          • Nasal Decongestant Plasters
        • Medicated Confectionery
        • Pharyngeal Preparations
      • Digestive Remedies
        • Child-Specific Digestive Remedies
          • Child-Specific Diarrhoeal Remedies
          • Child-Specific Indigestion and Heartburn Remedies
          • Child-Specific Laxatives
          • Child-Specific Motion Sickness Remedies
        • Diarrhoeal Remedies
        • IBS Treatments
        • Indigestion and Heartburn Remedies
          • Antacids
          • Antiflatulents
          • Digestive Enzymes
          • H2 Blockers
          • Proton Pump Inhibitors
        • Laxatives
        • Motion Sickness Remedies
      • Ear Care
      • Emergency Contraception
      • Eye Care
        • Allergy Eye Care
        • Standard Eye Care
      • Medicated Skin Care
        • Acne Treatments
        • Medicated Shampoos
        • Topical Antifungals
        • Vaginal Antifungals
        • Hair Loss Treatments
        • Nappy (Diaper) Rash Treatments
        • Antiparasitics/Lice (Head and Body) Treatments
        • Antipruritics
        • Child-Specific Medicated Skin Care
        • Cold Sore Treatments
        • Haemorrhoid Treatments
        • Topical Allergy Remedies/Antihistamines
        • Topical Germicidals/Antiseptics
      • NRT Smoking Cessation Aids
        • NRT Gum
        • NRT Inhalators
        • NRT Lozenges
        • NRT Patches
        • Other NRT
      • OTC Triptans
      • Wound Care
        • First Aid Kits
        • Sticking Plasters/Adhesive Bandages
        • Gauze, Tape and Other Wound Care
    • Sports Nutrition
    • Vitamins and Dietary Supplements
      • Child-Specific Vitamins and Dietary Supplements
      • Dietary Supplements
        • Combination Dietary Supplements
        • Herbal/Traditional Dietary Supplements
          • Combination Herbal/Traditional Dietary Supplements
          • Echinacea
          • Evening Primrose Oil
          • Garlic
          • Ginkgo Biloba
          • Ginseng
          • St John's Wort
          • Other Herbal/Traditional Dietary Supplements
          • Non-Herbal Dietary Supplements
            • Calcium Supplements
            • Co-Enzyme Q10
            • Combination Non-Herbal Dietary Supplements
            • Eye Health Supplements
            • Fish Oils
              • Cod Liver Oil
              • Other Fish Oils
            • Glucosamine
            • Mineral Supplements
            • Omega-3-6-9 (Fish and Non-Fish)
            • Probiotic Supplements
            • Protein Powder
            • Royal Jelly
            • Sam-E
            • Other Non-Herbal Dietary Supplements
          • Tonics and Bottled Nutritive Drinks
          • Vitamins
            • Multivitamins
            • Single Vitamins
              • Vitamin A
              • Vitamin B
              • Vitamin C
              • Vitamin D
              • Vitamin E
              • Other Single Vitamins
        • Weight Management
          • Meal Replacement Slimming
          • OTC Obesity
          • Slimming Teas
          • Weight Loss Supplements
          • Other Slimming Products
        • Herbal/Traditional Products
          • Herbal/Traditional Analgesics
          • Herbal/Traditional Calming and Sleeping Products
          • Herbal/Traditional Cough, Cold and Allergy (Hay Fever) Remedies
          • Herbal/Traditional Digestive Remedies
          • Herbal/Traditional Medicated Skin Care
          • Herbal/Traditional Medicinal Teas
          • Herbal/Traditional Smoking Cessation Aids
          • Herbal/Traditional Child-Specific Dietary Supplements
          • Herbal/Traditional Dietary Supplements
          • Herbal/Traditional Tonics and Bottled Nutritive Drinks
        • Allergy Care
          • Allergy Eye Care
          • Antihistamines/Allergy Remedies (Systemic)
          • Child-Specific Allergy Remedies
          • Topical Allergy Remedies/Antihistamines
        • Child-Specific Consumer Health
          • Child-Specific Analgesics
            • Child-Specific Acetaminophen
            • Child-Specific Aspirin
            • Child-Specific Combination Products - Analgesics
            • Child-Specific Diclofenac
            • Child-Specific Dipyrone
            • Child-Specific Ibuprofen
            • Child-Specific Ketoprofen
            • Child-Specific Naproxen
          • Child-Specific Cough, Cold and Allergy Remedies
            • Child-Specific Allergy Remedies
            • Child-Specific Cough/Cold Remedies
          • Child-Specific Digestive Remedies
            • Child-Specific Diarrhoeal Remedies
            • Child-Specific Indigestion and Heartburn Remedies
            • Child-Specific Laxatives
            • Child-Specific Motion Sickness Remedies
          • Child-Specific Medicated Skin Care
          • Nappy (Diaper) Rash Treatments
          • Child-Specific Vitamins and Dietary Supplements

      Statistics Included

      Statistics Included

      For each category and subcategory you will receive the following data in Excel format:

      From Passport

      • Market sizes
      • Company shares
      • Brand shares
      • Distribution
      • Analysis by format
      • Analysis by positioning
      • Analysis by type
      • Herbal/traditional vs standard
      • Pricing
      • Smoking incidence

      Market size details:

      • Retail volume
      • Retail volume % growth
      • Retail volume per capita
      • Retail value retail selling price % growth
      • Retail value retail selling price local currency, USD, EUR, GBP, CHF, JPY
      • Retail value retail selling price per capita local currency, USD, EUR, GBP, CHF, JPY
      • Retail value retail selling price real (constant 2008) prices % growth
      • Retail value retail selling price real (constant 2008) prices local currency, USD, EUR, GBP, CHF, JPY
      • Retail value retail selling price real (constant 2008) prices per capita local currency, USD, EUR, GBP, CHF, JPY
      • Retail value manufacturer selling price % growth
      • Retail value manufacturer selling price local currency, USD, EUR, GBP, CHF, JPY
      • Retail value manufacturer selling price per capita local currency, USD, EUR, GBP, CHF, JPY
      • Retail value manufacturer selling price real (constant 2008) prices % growth
      • Retail value manufacturer selling price real (constant 2008) prices local currency, USD, EUR, GBP, CHF, JPY
      • Retail value manufacturer selling price real (constant 2008) prices per capita local currency, USD, EUR, GBP, CHF, JPY
      • Retail value retail selling price nominal (current) prices % growth
      • Retail value retail selling price nominal (current) prices local currency, USD, EUR, GBP, CHF, JPY
      • Retail value retail selling price nominal (current) prices per capita local currency, USD, EUR, GBP, CHF, JPY
      • Retail value manufacturer selling price nominal (current) prices % growth
      • Retail value manufacturer selling price nominal (current) prices local currency, USD, EUR, GBP, CHF, JPY
      • Retail value manufacturer selling price nominal (current) prices per capita local currency, USD, EUR, GBP, CHF, JPY

      Methodology

      Methodology

      Global insight and local knowledge

      With 40 years’ experience of developed and emerging markets, Euromonitor International’s research method is built on a unique combination of specialist industry knowledge and in-country research expertise.

      This approach is what enables us to achieve our goal of building a market consensus view of size, shape and trends across the full distribution universe of each category. We factor in whichever channels are relevant, from large-scale grocery to direct sellers, from discount stores to local mom-and-pop outlets.

      Industry specialists

      Each industry we cover is managed by an Industry Manager and team of Industry Analysts who research and report on their specialist categories all year round.

      Our collaborative approach to research means that these industry teams are in constant dialogue with industry players and opinion formers. The planning of our research programmes reflects latest market trends and industry events. In completing each update project, this provides invaluable input to the testing, review and finalisation of our data.

      The specialist in-house teams bring together findings from all stages of the annual research process. They work closely with in-country analysts, assess and challenge data and exercise final editorial control over the publication of new data and analysis.

      Country and regional analysts

      Our in-country analyst network is managed by country and regional analysts in our offices around the world. Working closely with each in-country team, the regional research management team ensures that all country researchers are well schooled in best practices, from the information collected in store checks, to the dialogue we build in trade surveys. Our country analysts ensure that national reports explain the data trends and provide clear insights into the local market’s dynamics.

      In-country research network

      To deliver fresh insights every year in countries all around the world, we believe the strongest approach is to use analysts on the ground. They bring fluency in local language, physical proximity to the best sources, an ability to engage directly with local industry contacts, and an awareness of how the products and services we study are advertised, sold and consumed. These are essential parts of our ability to report incisively on these markets.

      Research Methodology

      Our research methods

      Each Euromonitor International industry report is based on a core set of research techniques:

      Desk research

      With industry events, corporate activity, trends and new product introductions tracked year round by our industry team, desk research provides a starting point for the in-country research programme. Our in-country researchers will access the following sources:

      • National statistics offices governmental and official sources
      • National and international trade press
      • National and international trade associations
      • Industry study groups and other semi-official sources
      • Company financials and annual reports
      • Broker reports
      • Online databases
      • The financial, business and mainstream press

      Accessing sources is only the first step. The ability to interpret and reconcile often conflicting information across multiple sources is a key aspect of the added value we provide.

      Store checks

      Store checks are an integral part of our methods for product industries. Carried out on the ground across a relevant mix of channels, the information gained provides first-hand insights into the products we are researching, specifically:

      • Place: We track products in all relevant channels, selective and mass, store and non-store
      • Product: What are innovations in products, pack sizes and formats?
      • Price: What are brand price variations across channels, how do private label’s prices compare to those of branded goods?
      • Promotion: What are marketing and merchandising trends, offers, discounts and tie-ins?

      Findings are cross-referenced with brand share data analysis. The results, combined with the findings of desk research, provide a strong basis for identifying key areas of questioning to take forward into our trade survey.

      Trade survey

      Interaction with global players at corporate HQ and regional levels is complemented by unique local data and insights from our in-country trade surveys around the world. Through the high profile of the Euromonitor International brand, we are able to talk directly to a wide range of sources and therefore inform our analysis with the knowledge and opinions of the leading operators in the market.

      Trade surveys allow us to:

      • Fill gaps in available published data per company
      • Generate a consensus view of the size, structure and strategic direction of the category
      • Access year-in-progress data where published sources are out of date
      • Evaluate the experts’ views on current trends and market developments

      In building our composite industry view, we engage with a variety of personnel in key players at all points of the supply chain: materials suppliers, manufacturers, distributors, retailers and service operators. We also interview desk research sources: industry associations; study groups; and third party observers from the trade and financial press.

      Our objective is to engage in conversation with trade sources in which we exchange ideas and views on the industry, sharing our work-in-progress findings on supply/demand dynamics and potential. This dialogue enhances both parties’ understanding of the local market. The scope and reach of our trade survey also serves to eliminate bias (intentional and unintentional) from any single source.

      Company analysis

      At a global level, our company research combines our mix of industry interaction and use of secondary sources such as annual accounts, broker reports, financial press and databases. From a data perspective, the aim is to build “top-down” estimates of major players’ total global and regional sales.

      At a country level, in line with local reporting requirements, we access annual accounts, national-specific company databases and local company websites. These are all invaluable sources as we build a view of each domestic player’s size and position within very specific categories of the industry.

      Forecasts

      Data projections and future performance analysis are key elements of Euromonitor International’s market intelligence. Working with historic trends of 15 years or more, a key aspect of our trade survey is to engage industry insider views of the next five years. Will volumes maintain their historic trend? Will price increases or falls of recent years continue, accelerate or slow down? Will increasing demand for one product cannibalise sales of another?

      Forecasts represent many of the essential conclusions we have reached about the current state of the market, how it works and how it behaves under different macro and micro conditions. Our written analysis will state the assumptions and the trade opinion behind whether our predictions are optimistic or pessimistic, so that clients can use our statistical forecasts with confidence.

      Data validation

      All data is subjected to an exhaustive review process, at country, regional and global levels.

      The interpretation and review of sources and data inputs forms a central part of the collaboration between industry teams and country researchers. Numbers are delivered to regional and global offices with an audit trail of sources and calculations to allow for a thorough evaluation of data sense and integrity.

      Upon completion of the country review phase, data is then reviewed on a comparative basis at regional and then at a global level. Comparative checks are carried out on per capita consumption and spending levels, growth rates, patterns of category and subcategory breakdowns and distribution of sales by channel. Top-down estimates are reviewed against bottom-up regional and global market and company sales totals.

      Where marked differences are seen between proximate country markets or ones at similar developmental levels, supplementary research is conducted in the relevant countries to confirm and/or amend those findings. This process ensures international comparability across the database, that consistent category and subcategory definitions have been used and that all data has been correctly tested. We make sure that possible discrepancies between different published sources have been reconciled and that our interpretation of opinion and expectation from each country’s trade sources has been applied to form a coherent international pattern.

      Market analysis

      Another integral part of all our research programmes is that all Euromonitor International data is accompanied by clear written analysis. From a research perspective, this explains and substantiates data findings. From a client perspective, this offers unique insights into local consumption trends, routes to market, brand preferences, channel dynamics and future trends.

      Our country level analysis also provides invaluable input into the ability of our central industry specialist teams to marry local insights with strategic conclusions on the direction of the market regionally and globally.

      my pages

      Want to find out more about this report?

      RELATED

      Future Demographic

      Country Report